Prostate Cancer Research
Funding research to increase survival and find a cure for men with advanced prostate cancer

What We Have Achieved Together in 12 Months

Thanks to our supporter community

We set our charity CEO, Oliver Kemp, with the challenge to list what we have achieved in the last year in 90 seconds thanks to your help.

Watch our 90 seconds challenge with Oliver Kemp

Dr Jennifer Munkley [left] and her research team

Our Research Highlights

  • Over the past five years, we have now invested over £7 million into prostate cancer research! Our research portfolio includes therapeutic innovation, next-generation diagnostic approaches, social science and patient-centred research
  • Our racial disparities research programme now includes ten active projects across the UK and US, with investment exceeding £2 million. These projects are informing national and international conversations about health equity in prostate cancer.
  • We launched reMOVE: a wellbeing-focused project that works with groups of people living with or at high risk of prostate cancer, building their resilience and health through guided online sessions delivered by a professional trainer.

Chris Ullman, CEO of Stratosvir [left] and Sonja Lawrence, associate Director for Proven Connect

Turning Research Into New Diagnostics and Treatments

  • Running the TAR Network, a group of over 40 non-profits who work together to get therapies into the clinic as quickly as possible
  • Our translational research arm, Proven Connect, continued to support emerging life science companies and collaborative initiatives through a combination of funding, strategic guidance, and access to expert networks.
  • We invested 50k into the following biotechnologies: Stratosvir Limited, Oxford Vacmedix and Nanovery, who are developing an engineered virus for drug delivery, a cancer vaccine immunotherapy and light-up nanorobots for detecting cancer markers. These companies are striving to transform the future of prostate cancer treatment and diagnosis.

The infopool website banner

Empowering People With Prostate Cancer

  • The infopool: in 2023, we launched the infopool, an online platform delivering trustworthy, accessible health information created by and for people with prostate cancer. By 2025, almost 200 hospitals were signposting to it and a quarter of a million people had used it!
  • Launched a new wellbeing project in partnership with Guy’s and St Thomas’, supporting men with prostate cancer through tailored physical activity, mental wellbeing resources, and peer support

Former UK Prime Minister, Rishi Sunak [left], PCR's Patient Advocate, Darren, Deputy Prime Minister, David Lammy, and Director of Patient Projects and Influencing, David James [right]

Advocating for National Screening

  • We engaged directly with senior political figures including the Chancellor, Secretary of State for Health, and Shadow Secretary of State for Health, advocating for prostate cancer to be prioritised in national screening efforts.
  • We completed a comprehensive Cost-Benefit Analysis (CBA) in early 2024/25. The analysis demonstrates that earlier detection of prostate cancer especially among high-risk groups not only saves lives but provides significant financial savings to the NHS and UK economy. This evidence forms the backbone of our national campaign to expand screening and reduce late diagnoses

Thank you for helping us transform lives through research. Your support allows us to continue fighting for patients and change lives.

Press enter or esc to cancel